Direct and Bone-Marrow Mediated Effects of Adipose Stem Cells in Emphysema
脂肪干细胞对肺气肿的直接作用和骨髓介导作用
基本信息
- 批准号:8392234
- 负责人:
- 金额:$ 37.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-12-15 至 2015-11-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAdipose tissueAdultAlveolarAlveolar CellAnti-Inflammatory AgentsAnti-inflammatoryApoptosisApoptoticAreaAutologousAutophagocytosisBiological PreservationBlood VesselsBlood capillariesBone MarrowBone Marrow CellsBone Marrow Stem CellCardiovascular systemCell DeathCell TherapyCellsCerebral IschemiaCerebrumCessation of lifeChronicChronic Obstructive Airway DiseaseCigaretteCigarette smoke-induced emphysemaCollaborationsDataDevelopmentDiseaseDistalEffectivenessFunctional disorderFutureGenesGoalsGrowthGrowth FactorHematopoiesisHumanHypocellular Bone MarrowInflammationInjuryInvestigationLabelLeadLungLung diseasesMaintenanceMediatingModelingMusMyocardialOrganOxidative StressPatientsPeptide HydrolasesPerfusionPlayPredispositionPropertyProtease InhibitorProteinsPulmonary EmphysemaQualifyingResearchRoleSignal TransductionSkeletal MuscleSmokeSmokingSourceStem cellsStromal CellsSuction LipectomySurfaceTNF geneTestingTherapeuticTissuesTransgenic MiceTransplantationVascular Endothelial Growth FactorsWorkalveolar destructioncapillarycigarette smoke-inducedcigarette smokingcytokineexperiencelung injurymultidisciplinarynovelparacrinepreventprogenitorprogramsprotective effectregenerativerelease factorrepairedstem cell biologystem cell therapytissue repairvascular bed
项目摘要
DESCRIPTION (provided by applicant): Pulmonary emphysema is a prevalent lung disease defined by permanent enlargement of airspaces, but also associated with systemic effects on organs that include the bone marrow and the cardiovascular system. Little is known about the mechanisms of systemic illness in emphysema and their impact, if any, on the lung disease. The lung destruction, clinically apparent after years of cigarette smoking has been attributed to protease-antiprotease imbalance, chronic inflammation, oxidative stress, and excessive alveolar cell death with loss of pulmonary capillaries that support the alveolar unit. We demonstrated that pluripotent cells contained in adipose stroma, called adipose stem or stromal cells promote capillary growth and limit ischemic tissue damage in models of acute skeletal muscle, myocardial, and cerebral ischemia and these salutary effects are mediated by angiogenic and anti-apoptotic paracrine factors. Given the feasibility of obtaining these stem cells, requiring no or limited ex vivo expansion, we tested the effect of adipose stem cells on cigarette smoke-induced murine emphysema. This form of regenerative treatment resulted in preservation of alveolar surface area and marked protection of the bone marrow from the suppressive effects of smoke on the number and cycling of multiple lineages of progenitor cells. We therefore generated the novel hypothesis that treatment with adipose stem cells will ameliorate the alveolar structural loss induced by cigarette smoking by decreasing lung structural cell death and reducing the loss of bone marrow-derived progenitor cells. To test this novel promising therapy for emphysema and to advance understanding of the crosstalk between the lung and bone marrow in emphysema development, we focused on 3 specific aims: 1. to determine the efficacy of adipose stem cells to limit cigarette smoke-induced murine emphysema; 2. to determine the effect of adipose stem cell treatment on the cigarette smoke-induced bone marrow-derived progenitor cell loss and to establish its importance to the development of emphysema; 3. to establish the role of adipose stem cell-secreted paracrine factors VEGF, HGF, and TSG-6 in the inhibition of lung destruction and of bone marrow hypoplasia induced by adipose stem cell exposure. We have assembled a multidisciplinary team with expertise in emphysema pathobiology, adipose stem cell-, vascular-, and bone marrow stem cell-biology to investigate the proposed comprehensive research plan. If completed, this work will determine the effectiveness, optimal approach, and mechanisms of adult, thus generally ethically accepted, adipose stem cell therapy in a relevant emphysema model, and will accelerate its implementation as a potential therapeutic approach in COPD.
描述(由申请人提供):肺气肿是一种常见的肺部疾病,其定义为永久性气腔扩大,但也与对器官(包括骨髓和心血管系统)的全身影响有关。关于肺气肿中全身性疾病的机制及其对肺部疾病的影响(如果有的话)知之甚少。多年吸烟后临床上明显的肺破坏归因于蛋白酶-抗蛋白酶失衡、慢性炎症、氧化应激和过度的肺泡细胞死亡以及支持肺泡单位的肺毛细血管的损失。我们证明,多能细胞包含在脂肪基质,称为脂肪干细胞或基质细胞促进毛细血管的生长和限制缺血性组织损伤的急性骨骼肌,心肌和脑缺血模型,这些有益的影响是由血管生成和抗凋亡旁分泌因子介导的。鉴于获得这些干细胞的可行性,不需要或需要有限的离体扩增,我们测试了脂肪干细胞对香烟烟雾诱导的小鼠肺气肿的影响。这种形式的再生治疗导致肺泡表面积的保存和骨髓的显着保护免受烟雾对祖细胞的多个谱系的数量和循环的抑制作用。因此,我们产生了新的假设,即脂肪干细胞治疗将通过减少肺结构细胞死亡和减少骨髓源性祖细胞的损失来改善吸烟诱导的肺泡结构损失。为了测试这种新的有希望的肺气肿治疗方法,并促进对肺气肿发展中肺和骨髓之间串扰的理解,我们专注于3个具体目标:1。确定脂肪干细胞限制香烟烟雾诱导的鼠肺气肿的功效; 2.确定脂肪干细胞治疗对香烟烟雾诱导的骨髓源祖细胞损失的影响,并确定其对肺气肿发展的重要性; 3.确定脂肪干细胞分泌的旁分泌因子VEGF、HGF和TSG-6在抑制脂肪干细胞暴露诱导的肺破坏和骨髓发育不全中的作用。我们已经组建了一个多学科团队,具有肺气肿病理生物学,脂肪干细胞,血管和骨髓干细胞生物学的专业知识,以调查拟议的综合研究计划。如果完成,这项工作将确定成人脂肪干细胞治疗的有效性,最佳方法和机制,从而在相关的肺气肿模型中被普遍接受,并将加速其作为COPD潜在治疗方法的实施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KEITH LEONARD MARCH其他文献
KEITH LEONARD MARCH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KEITH LEONARD MARCH', 18)}}的其他基金
Functional and Mechanistic Analysis of Mesenchymal Stem Cell Secretome to Ameliorate Ischemic Damage of Rodent Hearts in situ and Human Myocardium-on-a-Chip
间充质干细胞分泌组改善啮齿动物原位心脏和人心肌芯片缺血损伤的功能和机制分析
- 批准号:
9898148 - 财政年份:2017
- 资助金额:
$ 37.13万 - 项目类别:
Functional and Mechanistic Analysis of Mesenchymal Stem Cell Secretome to Ameliorate Ischemic Damage of Rodent Hearts in situ and Human Myocardium-on-a-Chip
间充质干细胞分泌组改善啮齿动物原位心脏和人心肌芯片缺血损伤的功能和机制分析
- 批准号:
10394875 - 财政年份:2017
- 资助金额:
$ 37.13万 - 项目类别:
Functional and Mechanistic Analysis of Mesenchymal Stem Cell Secretome to Ameliorate Ischemic Damage of Rodent Hearts in situ and Human Myocardium-on-a-Chip
间充质干细胞分泌组改善啮齿动物原位心脏和人心肌芯片缺血损伤的功能和机制分析
- 批准号:
9352535 - 财政年份:2017
- 资助金额:
$ 37.13万 - 项目类别:
Functional and Mechanistic Analysis of Mesenchymal Stem Cell Secretome to Ameliorate Ischemic Damage of Rodent Hearts in situ and Human Myocardium-on-a-Chip
间充质干细胞分泌组改善啮齿动物原位心脏和人心肌芯片缺血损伤的功能和机制分析
- 批准号:
10265387 - 财政年份:2017
- 资助金额:
$ 37.13万 - 项目类别:
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
自体和同种异体细胞疗法在外周动脉疾病中的应用
- 批准号:
9039127 - 财政年份:2012
- 资助金额:
$ 37.13万 - 项目类别:
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
自体和同种异体细胞疗法在外周动脉疾病中的应用
- 批准号:
8622215 - 财政年份:2012
- 资助金额:
$ 37.13万 - 项目类别:
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
自体和同种异体细胞疗法在外周动脉疾病中的应用
- 批准号:
8815330 - 财政年份:2012
- 资助金额:
$ 37.13万 - 项目类别:
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
自体和同种异体细胞疗法在外周动脉疾病中的应用
- 批准号:
8443414 - 财政年份:2012
- 资助金额:
$ 37.13万 - 项目类别:
Utility of Autologous and Allogeneic Cell Therapy for Peripheral Arterial Disease
自体和同种异体细胞疗法在外周动脉疾病中的应用
- 批准号:
8288419 - 财政年份:2012
- 资助金额:
$ 37.13万 - 项目类别:
Direct and Bone-Marrow Mediated Effects of Adipose Stem Cells in Emphysema
脂肪干细胞对肺气肿的直接作用和骨髓介导作用
- 批准号:
8802885 - 财政年份:2011
- 资助金额:
$ 37.13万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 37.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
Operating Grants